January 19, 2017, Cambridge, Mass., USA - Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, appoints Richard Peters as president and CEO, effective February 6, 2017, at which time he will also be appointed to the Merrimack board of directors.
January 19, 2017, Oxford, United Kingdom - Summit Therapeutics, a biopharmaceutical company, announced the appointment of David Roblin as chief operating officer and president of research and development.
January 19, 2017, London, United Kingdom - Thorn Medical PLC, a healthcare group, announces the appointment of Paul Christie as chief operating officer and Gordon McIvor Wilson as development director.
January 19, 2017, Rosemont, Ill., USA - US Foods Holding Corp. announced that Andrew Iacobucci will join the company as chief merchandising officer from January 23, 2017.
January 19, 2017, York, United Kingdom - OptiBiotix Health, a life sciences business, announced the appointment of Christina Wood as sales and marketing director.
January 19, 2017, London, United Kingdom - McKay Securities, a real estate investment trust, appoints Jeremy Bates to the board as an independent non-executive director and as a member of the audit, remuneration and nomination committees.
January 19, 2017, Warren, N.J., USA - Roka Bioscience, a molecular diagnostics company, announced the appointment of Mary Duseau as president and CEO.